globenewswire.com/news-rele...
Long way to go on this one but incredibly positive results. Usual early stage caveat of it could just be placebo. Will be interesting to see what the next cohort with a dosage of 4 times higher will do.
globenewswire.com/news-rele...
Long way to go on this one but incredibly positive results. Usual early stage caveat of it could just be placebo. Will be interesting to see what the next cohort with a dosage of 4 times higher will do.
Very interesting! Corporate presentation here:
investors.axovant.com/stati...
They are still in phase 2 and it will take some years to do phase 3. It does take brain surgery to get this treatment in place. With all that said it does look like they are getting results.
Wow! I never saw the detailed old prosavin data before. The data is 6 years. Surely the placebo effect cant last 6 years. The prosavin data shows it was dose dependent meaning the higher the dose, the better the improvement. The 1st cohort data is already better than the highest in prosavin data. I know the numbers are tiny but If the 2nd cohort shows the same, then I think we may be onto something.
I have posted this before but I think it will inspire you Parkinsonjisung.
youtube.com/watch?list=PL6E...
Ya. I saw that before. Completely forgot it was for prosavin. That video is 6 years old. Itd be very interesting to see how stelia is doing now. Based off the data in the presentation, it seems she probably hasn't progressed much.